Benzinga Rankings give you vital metrics on any stock – anytime.
Explore Monopar Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for MNPR.
You can purchase shares of Monopar Therapeutics (NASDAQ:MNPR) through any online brokerage.
Other companies in Monopar Therapeutics’s space includes: Humacyte (NASDAQ:HUMA), Abeona Therapeutics (NASDAQ:ABEO), Design Therapeutics (NASDAQ:DSGN), Emergent BioSolutions (NYSE:EBS) and 2seventy bio (NASDAQ:TSVT).
Monopar Therapeutics has a consensus price target of $39.29.
The stock price for Monopar Therapeutics (NASDAQ: MNPR) is $42.9 last updated April 24, 2025 at 1:56 PM EDT.
There are no upcoming dividends for Monopar Therapeutics.
Monopar Therapeutics’s Q1 earnings are confirmed for Thursday, May 8, 2025.
There is no upcoming split for Monopar Therapeutics.
Monopar Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.